Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram with Lithium or Placebo for Depressive Mood Disorders
NCT01189812Phase 2Completed
- Sponsor
- Columbia Northwest Pharmaceuticals
- Start
- Mar 2010
- Primary completion
- Jan 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in major depressive disorder (MDD), persistent depressive disorder (PDD), depressive disorder not otherwise specified (DD-NOS), borderline personality disorder (BPD), sponsored by Columbia Northwest Pharmaceuticals. Started Mar 2010; status: completed.
02
Drugs
lithium carbonate
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)depressive disorder not otherwise specified (DD-NOS)borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT01189812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189812.